Posted on Jun 14, 2011 By Jennifer Williams, Esq.
The Food and Drug Administration announced June 9, 2011 that the "Warnings and Precautions" section of labeling for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include ...
Continue reading "Proscar, Propecia, Avodart and Jalyn Get New Prostate Cancer Warnings" »